StockData
OS Therapies Inc logo

OS Therapies Inc (OSTX) shareholders

OSTXNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.74+0.06 (+9.42%)

Close on Nov 17, 2026Market cap $34.35MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
6.3%
3M of 46M shares
Institutional holders
29
6 new, 6 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Thomas A. Satterfield, Jr.5,434,1509.90%13G (passive) amendmentSep 30, 2026
Shalom Auerbach
Joint filing with Einodmil LLC (8.40%)
2,677,5708.50%13D (active) amendmentJul 29, 2025
Ayala Pharmaceuticals, Inc.2,164,2159.99%13G (passive)Apr 9, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of OSTXValueChange% of portfolio
Vanguard Capital Management LLC777,6511.69%$1.48M+308,1840.00%
CM Management, LLC400,0000.87%$760.00K–0.51%
Geode Capital Management, LLC301,7940.65%$573.41K+21,7490.00%
Howard Financial Services, Ltd.248,0010.54%$471.20K+2,5650.05%
BlackRock, Inc.242,4790.53%$460.71K+177,7070.00%
Vanguard Fiduciary Trust Co174,1320.38%$330.85K+57,4690.00%
State Street Corp120,1000.26%$228.19K+28,9000.00%
Marshall Wace, Llp100,6400.22%$191.22KNew0.00%
HighTower Advisors, LLC85,5500.19%$162.55K+70,3500.00%
Northern Trust Corp70,8170.15%$134.55K+4,7630.00%
Beacon Pointe Advisors, LLC62,5070.14%$118.76K–0.00%
Bridgeway Capital Management, LLC45,0000.10%$85.50K+20,0000.00%
Ingalls & Snyder LLC36,6760.08%$70.00K–0.00%
Two Sigma Investments, LP30,4140.07%$57.79K+4,0340.00%
Stifel Financial Corp27,9000.06%$53.01K+12,9000.00%
Jane Street Group, LLC26,9990.06%$51.30K−13,3170.00%
Axq Capital, LP24,6230.05%$46.78KNew0.01%
Vanguard Global Advisers, LLC20,9580.05%$39.82K–0.00%
Stratos Wealth Advisors, LLC19,3140.04%$36.70K+5,4970.00%
Quadrature Capital Ltd15,6620.03%$29.76KNew0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026293M6.3%6 / 153 / 61M1M
Q1 2026293M6.3%11 / 82 / 62M0M
Q4 2025252M3.8%7 / 84 / 61M0M
Q3 2025252M3.4%13 / 52 / 11M0M
Q2 2025131M1.3%7 / 21 / 00M0M
Q1 202560M0.8%2 / 21 / 10M0M
Q4 202450M0.3%2 / 11 / 40M0M
Q3 202470M0.3%7 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

9 funds held OSTX in Q2 2026, 77% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of OSTXValue% of fundAs of
Vanguard Total Stock Market Index Fund416,1150.90%$790.62K0.00%Jun 30, 2026
Vanguard Extended Market Index Fund361,5360.78%$686.92K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund145,1350.31%$310.59K0.00%May 31, 2026
iShares Micro-Cap ETF110,4320.24%$209.82K0.01%Jun 30, 2026
Ultra-Small Company Market Fund45,0000.10%$85.50K0.06%Jun 30, 2026
Fidelity Series Total Market Index Fund34,8840.08%$74.65K0.00%May 31, 2026
Fidelity Total Market Index Fund32,8440.07%$70.29K0.00%May 31, 2026
1290 VT Micro Cap Portfolio7,4360.02%$14.13K0.01%Jun 30, 2026
Blackstone Alternative Multi-Strategy Fund-1,800-0.00%-$3.42K-0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Paul A. RomnessPresident and CEO, Director2,473,0005.36%Oct 30, 2026
Kerry M. ClemChief Commercial Officer225,0000.49%Nov 12, 2026
Knuettel Francis IIChief Financial Officer270,0000.59%Nov 12, 2026
Robert PetitSee Remarks200,0000.43%Oct 30, 2026
Christopher P. AcevedoChief Financial Officer109,3750.24%Feb 13, 2026
Craig EagleDirector––Oct 30, 2026
Olivier Roger JarryDirector––Oct 30, 2026
Theodore F. SearchDirector455,8350.99%Oct 30, 2026
John CiccioDirector455,8350.99%Oct 30, 2026
Avril Suzette McKean-DieserDirector5,0000.01%Oct 30, 2026
Karim GalzahrDirector––Feb 13, 2026
Colin GoddardDirector225,1790.49%Feb 14, 2025
LLC Einodmil–2,829,5826.13%May 9, 2025
Shalom Auerbach–2,687,5705.83%May 9, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Knuettel Francis II
Chief Financial Officer
Nov 10, 2026Award+250,000––250,000
Kerry M. Clem
Chief Commercial Officer
Nov 10, 2026Award+200,000––225,000
Shalom Auerbach
10% owner
May 7, 2025Sale−82,000$2.00$164.00K2,664,199
Shalom Auerbach
10% owner
Apr 10, 2025Sale−10,000$1.39$13.90K2,746,199
Shalom Auerbach
10% owner
Apr 9, 2025Sale−50,012$1.35$67.52K2,756,199
Paul A. Romness
President and CEO, Director, 10% owner
Feb 28, 2025Other+225,000––2,473,000
LLC Einodmil
10% owner
Feb 27, 2025Other−225,000$1.64$369.00K2,806,211
LLC Einodmil
10% owner
Feb 14, 2025Sale−100,000$2.84$284.00K2,431,211
Shalom Auerbach
10% owner
Jan 15, 2025Sale−16,720$6.74$112.69K2,531,211
Shalom Auerbach
10% owner
Aug 2, 2024Conversion+270,465––1,736,306
Shalom Auerbach
10% owner
Aug 2, 2024Conversion+23,371––23,371
Shalom Auerbach
10% owner
Aug 2, 2024Conversion+633,980––1,438,355
Shalom Auerbach
10% owner
Aug 2, 2024Conversion+27,486––1,465,841
Shalom Auerbach
10% owner
Aug 2, 2024Conversion+53,468––1,789,774
Shalom Auerbach
10% owner
Aug 2, 2024Conversion+131,472––1,921,246
Shalom Auerbach
10% owner
Aug 2, 2024Conversion+78,710––1,999,956
Shalom Auerbach
10% owner
Aug 2, 2024Conversion+88,940––2,088,896
Shalom Auerbach
10% owner
Aug 2, 2024Conversion+179,027––2,267,923
Shalom Auerbach
10% owner
Aug 2, 2024Conversion+51,035––2,318,958
Shalom Auerbach
10% owner
Aug 2, 2024Conversion+178,135––2,497,093
Shalom Auerbach
10% owner
Aug 2, 2024Conversion+50,838––2,547,931
John Ciccio
Director
Aug 2, 2024Conversion+30,264––435,835
John Ciccio
Director
Aug 2, 2024Conversion+101,765––139,265
John Ciccio
Director
Aug 2, 2024Conversion+266,306––405,571
Theodore F. Search
Director
Aug 2, 2024Conversion+30,264––435,835
Theodore F. Search
Director
Aug 2, 2024Conversion+101,765––139,265
Theodore F. Search
Director
Aug 2, 2024Conversion+266,306––405,571

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
6.99%
3M shares short
Days to cover
7.7
At 0M shares a day
Change since last report
-2.1%
From 3M shares
Short volume, 20 days
45.2%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of OS Therapies's stock actually held short. Settlement fails (shares not delivered on time) peaked at 14,528 shares on Sep 18, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
LLC Einodmil
10% stockholder
May 7, 20251,200,000$2.81MMay 7, 2025Shares of common stock of the Issuer that were issued upon the automatic conversion of convertible promissory notes held by Einodmil LLC, which occurred upon the consummation of the Issuer's initial p

See a number that looks wrong?